Michael T. Zelasky
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 3
- Antifungal resistance and susceptibility 1
-
- Urinary Tract Infections Management 3
- Co-authors
- Robert C. Holman (5 shared papers)Michael W. Dunne (7 shared papers)Sailaja Puttagunta (5 shared papers)Philip Giordano (2 shared papers)Dainis Krieviņš (2 shared papers)James Baldassarre (1 shared paper)James W. Buehler (2 shared papers)Robert S. Janssen (2 shared papers)
- Journals
- Clinical Infectious Diseases (4 papers)Neurology (2 papers)Open Forum Infectious Diseases (2 papers)American Journal of Public Health (2 papers)Clinical Microbiology and Infection (1 paper)
- Partner nations
- United StatesLatvia
In The Last Decade
Michael T. Zelasky
13 papers receiving 539 citations
Peers
Comparison fields: 5 of 71
- Applied Microbiology and Biotechnology 36
- Molecular Medicine 71
- Infectious Diseases 191
- Clinical Biochemistry 55
- Pharmacology 81
Countries citing papers authored by Michael T. Zelasky
This map shows the geographic impact of Michael T. Zelasky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Zelasky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Zelasky more than expected).
Fields of papers citing papers by Michael T. Zelasky
This network shows the impact of papers produced by Michael T. Zelasky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Zelasky. The network helps show where Michael T. Zelasky may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael T. Zelasky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 176 | |
| 2 | 1991 | 92 | |
| 3 | 1999 | 73 | |
| 4 | 1989 | 64 | |
| 5 | 1998 | 49 | |
| 6 | 2022 | 29 | |
| 7 | 2022 | 25 | |
| 8 | Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates. | 1991 | 22 |
| 9 | 2020 | 11 | |
| 10 | 1990 | 9 | |
| 11 | 2024 | 8 | |
| 12 | 2015 | 4 | |
| 13 | 1992 | 1 |
About Michael T. Zelasky
Michael T. Zelasky is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Hematology and Surgery, having authored 13 papers that have together received 563 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Urinary Tract Infections Management (3 papers), Blood properties and coagulation (1 paper), Hemophilia Treatment and Research (1 paper), Antifungal resistance and susceptibility (1 paper), Polyomavirus and related diseases (1 paper) and Plant Disease Resistance and Genetics (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (36 citations), Molecular Medicine (71 citations), Infectious Diseases (191 citations), Clinical Biochemistry (55 citations) and Pharmacology (81 citations). Michael T. Zelasky has collaborated with scholars based in United States and Latvia. Frequent co-authors include Robert C. Holman, Michael W. Dunne, Sailaja Puttagunta, Philip Giordano, Dainis Krieviņš, James Baldassarre, James W. Buehler, Robert S. Janssen, W. Craig Hooper and Anita Das. Their work appears in journals such as Clinical Infectious Diseases, Neurology, Open Forum Infectious Diseases, American Journal of Public Health and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.